Cardiac Prosthetic Devices Market
Cardiac Prosthetic Devices Market Analysis By Product Type (Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves, Mechanical Heart Valves), By End User (Hospitals, Specialty Centers, Ambulatory Surgical Centers) & Region - Global Market Insights 2022 to 2027
Analysis of Cardiac Prosthetic Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cardiac Prosthetic Devices Market Outlook (2022 to 2027)
Global sales of cardiac prosthetic devices are predicted to increase at a CAGR of 7.6% from 2022 to 2027. In 2022, the global cardiac prosthetic devices market is valued at US$ 6.6 billion and is projected to reach a market size of US$ 9.5 billion by 2027.
Demand for implantable pacemakers is expected to rise at a prolific CAGR of 8% through 2027. Compared to conventional pacemakers, implantable pacemakers improve the heart's efficiency and increase blood flow. They offer a few further benefits such as precise shock delivery and heart rate detection.
| Report Attributes | Details |
|---|---|
| Cardiac Prosthetic Devices Market Size (2022) | US$ 6.6 Billion |
| Projected Market Value (2027) | US$ 9.5 Billion |
| Global Market Growth Rate (2022 to 2027) | 7.6% CAGR |
| Market Share of Implantable Pacemakers | 40% |
| Share in Cardiovascular Devices Market (2022) | 12% |
| Key Companies Profiled | CryoLife, Inc.; TTK Healthcare; Venus Medtech; Vitatron; Abiomed, Inc.; AtriCure, Inc.; Biotronik; Boston Scientific Corporation; Braile Biomedica; Abbott Laboratories; Edwards Lifesciences Corporation; Labcor Laboratrios; Lepu Medical Technology Co. Ltd.; Lifetech Scientific |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Sales Analysis of Cardiac Prosthetic Devices (2017 to 2021) Vs. Market Estimates (2022 to 2027)
“Rising Prevalence of Cardiovascular Diseases Driving Demand for Cardiac Prosthetic Devices”
According to Fact.MR, a market research and competitive intelligence provider, demand for cardiac prosthetic devices is projected to increase at a CAGR of 7.6% from 2022 to 2027.
Heart valve obstructions are treated with cardiac prosthetic devices. A rise in the number of patients with valvular heart disorders has led to an increased acceptance of cardiac prosthetic device implantation as one of the standard procedures.
One of the key factors accelerating market growth during the forecast period is the high prevalence of cardiovascular diseases (CVDs) among the senior population base in combination with the rapid technological advancements in cardiovascular repair and reconstruction devices.
The development of new prosthetic heart devices and the revolution in patient treatment with severe heart failure are the factors driving market revenue.
How is the Market for Cardiac Prosthetic Devices Evolving?
“Constant Innovations in Pacemaker Technology”
Cardiac prosthetic devices improve patients' cardiac function by taking the place of or helping the native heart tissues or organs that have been damaged or become ill. Cardiac prosthetic instruments are implanted permanently or only temporarily to replace and repair artificial heart tissue.
The management of valvular heart illnesses such as regurgitation and stenosis in the aorta and mitral valve has greatly benefited from technological innovations in products, particularly in the various types of valves available on the market. The global use of cardiac prosthetic equipment has been spurred by advancements in pacemaker technology. To prevent abrupt cardiac arrest in the event of arrhythmias, the next-generation implantable cardioverter defibrillators (ICDs) also operate as pacemakers.
“Development of Small Artificial Hearts & Rising Geriatric Population”
An important factor in the rising need for cardiac prosthetic systems is the ageing population. They are more likely to develop degenerative heart illnesses, which is anticipated to have a significant favorable impact on the market. Consequently, it is predicted that the risk of cardiovascular disorders will increase as the geriatric population grows. Inpatient stays for cardiovascular illnesses are more likely to last longer in the senior population base.
Due to the majority of the population's unhealthy lifestyles and poor dietary practices, heart diseases and several cardiac illnesses are becoming more common in many different areas. Accordingly, a rise in the number of people with Marfan syndrome, which affects the lungs, heart, and other important organs, is causing the market to grow. The dysfunctional aorta and heart valve collapse that occurs in people with this inherited connective tissue disease may eventually call for the implantation of a cardiac prosthetic device as a treatment option for the heart's healthy operation.
The development of small artificial hearts and suture-free valve repairs are two examples of recent technological advances that have contributed to industry growth. These implants can be put into a patient's body utilizing minimally-invasive procedures and are constructed of durable, biocompatible materials.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Can Adversely Affect Cardiac Prosthetic Device Demand Growth?
“High Cost & Strict Guidelines for Cardiovascular Prosthetic Device Approval”
The factors impeding market growth include high prices for products and services, strict guidelines for cardiovascular prosthetic device approval, and the risk of repetitive procedures.
Market expansion is expected to be hampered by instances of difficulties related to device implantation and the implementation of excise duties on medical devices.
Prosthetic valves frequently fail for several reasons, including implant techniques or risk factors such as metabolic syndrome, smoking, diabetes, and high cholesterol.
How are Emerging Companies Contributing to Market Growth?
“Start-ups Implementing Advanced Techniques to Extend Product Life”
New entrants are putting novel ideas into practice to stay competitive in the market. New companies are implementing advanced techniques to extend the life of their products.
- A start-up based in the U.S. - VoltXon - offers a pacemaker without batteries. The startup's VX-P8 device features an exclusive energy harvesting and storage technique based on graphene. Biosupercapacitors are used to store the energy that is taken from the patient's body. The startup's technology enables long-lasting cardiac pacemakers, which are a more practical replacement for the conventional battery-powered pacemakers that only last a few years.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Region Has Bright Investment Scope for Cardiac Prosthetic Device Manufacturers?
“Growing Focus on Improving Health by Local Organizations in North America”
North America accounts for the highest share of the cardiac prosthetic devices market due to the high prevalence of cardiovascular ailments. Increasing demand for synthetic grafts, pericardial tissue patches, and synthetic patches, the rapid expansion of the healthcare industry, and the growing usage of vascular prosthetic devices are the factors driving market growth.
The American Heart Association is emphasizing the prevention of cardiovascular disease through the encouragement of good health. The market value in North America is being driven by the presence of technologically advanced infrastructure, rising levels of public awareness, and highly qualified healthcare personnel.
Market growth is fueled by favorable health reimbursement policies, a growing focus on improving health by local organizations, and increased annuloplasty ring sales.
Country-wise Insights
How is the Market for Cardiac Prosthetic Devices Progressing in the U.S.?
“High Awareness & Accessibility of Cardiac Prosthetic Devices”
A significant element driving market expansion in the United States is the high awareness and accessibility of cardiac prosthetic machines. Due to their poor lifestyles compared to the elderly population, cardiovascular illnesses are more common in children and young adults in the United States.
Rising adoption of endovascular devices, vascular stents, and artificial hearts, an increase in the number of procedures performed to repair and replace valves, and a growing preference for minimally invasive techniques are driving market expansion.
The market is growing as a result of the increasing incidence of heart rhythm disorders & heart valve disease, rapid uptake of upgraded heart valve devices, and an increase in healthcare spending.
Why are Sales of Cardiac Prosthetic Devices Flourishing in China?
“Rapidly Increasing Acceptance of Tissue Heart Valves in China”
The cardiac prosthetic devices market in China is expected to increase at a CAGR of 11% from 2022 to 2027.
The market for cardiac prosthetic devices is expanding as a result of rising demand for right, left, and bipolar ventricular assist devices, rising disposable income, and rising public preference for accessing advanced medical treatments.
The drivers propelling market expansion include expanding the geriatric and obese population, more governmental involvement in enhancing the overall healthcare sector, rapid acceptance of tissue heart valves, and rising adoption of ventricular assist devices.
Category-wise Insights
Why are Implantable Pacemakers Most Widely Used?
“Rising Rates of Pacemaker Implantation among Ageing Population to Restore Normal Heart Rates”
By product type, the cardiac prosthetic devices market is divided into implantable pacemakers, external pacemakers, transcatheter heart valves, tissue heart valves, and mechanical heart valves. Implantable pacemakers account for 40% share of the global market.
Due to the rising rates of cardiac pacemaker implantation among the ageing population, there is an increased demand for implantable pacemakers. The numerous product advantages, such as its capacity to alleviate signs of an irregular, sluggish heartbeat and restore normal heart rates, which in turn also helps erase the signs of bradycardia, will further spur the segment growth.
Recent innovations in implantable pacemakers, including dynamic pacemaker technology and microprocessor-controlled devices, are improving device efficiency and fostering market expansion.
Pacemakers that can be implanted help manage irregular heart rhythms. Patients with cardiac arrhythmia, a heart condition characterized by an irregular heartbeat pattern, have these devices implanted.
Which End User Accounts for High Usage of Cardiac Prosthetic Devices?
“Easy Availability of Modern Cardiovascular Prosthetics in Hospitals”
The cardiac prosthetic devices market is segmented into hospitals, specialty centers, ambulatory surgical centers, and others based on end user.
Demand for cardiac prosthetic devices in hospitals is expected to rise at a significant CAGR over the forecast period. The segment growth is being fueled by the rising incidence of heart conditions and the rising number of hospital implantations. Modern cardiovascular prosthetics are used in hospitals by medical professionals to treat cardiac illnesses, including stented and stentless tissue valves, flexible annuloplasty rings, and prosthetic heart valves.
The expansion of the hospital segment is primarily driven by an increase in hospital procedures, attractive health reimbursement, and improved government standards for the care of vulvar illnesses.
Competitive Landscape
Key suppliers of cardiac prosthetic devices are focused on offering a wide range of advanced and innovative devices. Cardiac device manufacturers are concentrating on technological advancements to fulfil the unmet demands of cardiac illnesses. Top market companies are implementing product approval and acquisition to bolster their R&D division and create superior cardiac prosthetic devices.
For instance :
- In 2020, CMS increased its coverage for artificial hearts and ventricular assist devices with the fulfilment of the Medicare regulations to provide more patients with a range of prosthetic heart devices such as Abbott's HeartMate 3.
Cardiac Prosthetic Devices Industry Research Segments
-
By Product Type :
- Implantable Pacemakers
- External Pacemakers
- Transcatheter Heart Valves
- Tissue Heart Valves
- Mechanical Heart Valves
-
By End User :
- Hospitals
- Specialty Centers
- Ambulatory Surgical Centers
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Product Type
- 9.1. Implantable Pacemakers
- 9.2. External Pacemakers
- 9.3. Transcatheter Heart Valves
- 9.4. Tissue Heart Valves
- 9.5. Mechanical Heart Valves
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by End User
- 10.1. Hospitals
- 10.2. Specialty Centers
- 10.3. Ambulatory Surgical Centers
- 10.4. Others
- 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 17. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 18. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 19. Key and Emerging Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. CryoLife, Inc.
- 21.2. TTK Healthcare
- 21.3. Venus Medtech
- 21.4. Vitatron
- 21.5. Abiomed, Inc.
- 21.6. AtriCure, Inc.
- 21.7. Biotronik
- 21.8. Boston Scientific Corporation
- 21.9. Braile Biomedica
- 21.10. Abbott Laboratories
- 21.11. Edwards Lifesciences Corporation
- 21.12. Labcor Laboratrios
- 21.13. Lepu Medical Technology Co. Ltd.
- 21.14. Lifetech Scientific
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Product Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2017 to 2021
Figure 02: Global Market Volume Forecast (in 000' Units), 2022 to 2027
Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 05: Global Market Value Analysis (US$ Mn), 2017 to 2021
Figure 06: Global Market Value Forecast (US$ Mn), 2022 to 2027
Figure 07: Global Market Absolute $ Opportunity, 2022 to 2027
Figure 08: Global Market Share Analysis (%), By Product Type, 2022 to 2027
Figure 09: Global Market Y-o-Y Analysis (%), By Product Type, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 11: Global Market Share Analysis (%), By End User, 2022 to 2027
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2027
Figure 14: Global Market Share Analysis (%), By Region, 2022 to 2027
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value Share, By Product Type, 2022 (E)
Figure 18: North America Market Value Share, By End User, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 21: North America Market Value Forecast (US$ Mn), 2022 to 2027
Figure 22: North America Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 24: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 25: Latin America Market Value Share, By Product Type, 2022 (E)
Figure 26: Latin America Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 29: Latin America Market Value Forecast (US$ Mn), 2022 to 2027
Figure 30: Latin America Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 31: Latin America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 32: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 33: Europe Market Value Share, By Product Type, 2022 (E)
Figure 34: Europe Market Value Share, By End User, 2022 (E)
Figure 35: Europe Market Value Share, By Country, 2022 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2017 to 2021
Figure 37: Europe Market Value Forecast (US$ Mn), 2022 to 2027
Figure 38: Europe Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 39: Europe Market Attractiveness Analysis by End User, 2022 to 2027
Figure 40: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 41: South Asia Market Value Share, By Product Type, 2022 (E)
Figure 42: South Asia Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 45: South Asia Market Value Forecast (US$ Mn), 2022 to 2027
Figure 46: South Asia Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 47: South Asia Market Attractiveness Analysis by End User, 2022 to 2027
Figure 48: South Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 49: East Asia Market Value Share, By Product Type, 2022 (E)
Figure 50: East Asia Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 53: East Asia Market Value Forecast (US$ Mn), 2022 to 2027
Figure 54: East Asia Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 55: East Asia Market Attractiveness Analysis by End User, 2022 to 2027
Figure 56: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 57: Oceania Market Value Share, By Product Type, 2022 (E)
Figure 58: Oceania Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2017 to 2021
Figure 61: Oceania Market Value Forecast (US$ Mn), 2022 to 2027
Figure 62: Oceania Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 63: Oceania Market Attractiveness Analysis by End User, 2022 to 2027
Figure 64: Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 65: Middle East and Africa Market Value Share, By Product Type, 2022 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2017 to 2021
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2022 to 2027
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product Type, 2022 to 2027
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2022 to 2027
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2022 to 2027
Figure 73: U. S. Market Value Analysis (US$ Mn), 2022 & 2027
Figure 74: U. S. Market Value Share, By Product Type, 2022 (E)
Figure 75: U. S. Market Value Share, By End User, 2022 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2022 & 2027
Figure 77: Canada Market Value Share, By Product Type, 2022 (E)
Figure 78: Canada Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2022 & 2027
Figure 80: Mexico Market Value Share, By Product Type, 2022 (E)
Figure 81: Mexico Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2022 & 2027
Figure 83: Brazil Market Value Share, By Product Type, 2022 (E)
Figure 84: Brazil Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2022 & 2027
Figure 86: U. K. Market Value Share, By Product Type, 2022 (E)
Figure 87: U. K. Market Value Share, By End User, 2022 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2022 & 2027
Figure 89: Germany Market Value Share, By Product Type, 2022 (E)
Figure 90: Germany Market Value Share, By End User, 2022 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2022 & 2027
Figure 92: France Market Value Share, By Product Type, 2022 (E)
Figure 93: France Market Value Share, By End User, 2022 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2022 & 2027
Figure 95: Italy Market Value Share, By Product Type, 2022 (E)
Figure 96: Italy Market Value Share, By End User, 2022 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2022 & 2027
Figure 98: Spain Market Value Share, By Product Type, 2022 (E)
Figure 99: Spain Market Value Share, By End User, 2022 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2022 & 2027
Figure 101: Russia Market Value Share, By Product Type, 2022 (E)
Figure 102: Russia Market Value Share, By End User, 2022 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2022 & 2027
Figure 104: China Market Value Share, By Product Type, 2022 (E)
Figure 105: China Market Value Share, By End User, 2022 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2022 & 2027
Figure 107: Japan Market Value Share, By Product Type, 2022 (E)
Figure 108: Japan Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2022 & 2027
Figure 110: South Korea Market Value Share, By Product Type, 2022 (E)
Figure 111: South Korea Market Value Share, By End User, 2022 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2022 & 2027
Figure 113: India Market Value Share, By Product Type, 2022 (E)
Figure 114: India Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2022 & 2027
Figure 116: ASEAN Market Value Share, By Product Type, 2022 (E)
Figure 117: ASEAN Market Value Share, By End User, 2022 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2022 & 2027
Figure 119: Australia Market Value Share, By Product Type, 2022 (E)
Figure 120: Australia Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2022 & 2027
Figure 122: New Zealand Market Value Share, By Product Type, 2022 (E)
Figure 123: New Zealand Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2027
Figure 125: GCC Countries Market Value Share, By Product Type, 2022 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2022 & 2027
Figure 128: Turkey Market Value Share, By Product Type, 2022 (E)
Figure 129: Turkey Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2022 & 2027
Figure 131: South Africa Market Value Share, By Product Type, 2022 (E)
Figure 132: South Africa Market Value Share, By End User, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the cardiac prosthetic devices market size?
Currently, the global cardiac prosthetic devices market is valued at US$ 6.6 billion.
What is the projected size & growth rate for the cardiac prosthetic devices market?
The market for cardiac prosthetic devices is expected to reach US$ 9.5 billion by 2027, expanding at a CAGR of 7.6%.
Which product has the largest share in the market?
Implantable pacemakers account for 40% share of the global market.
What is the estimated CAGR for the market in Japan?
Sales of cardiac prosthetic devices in Japan are set to rise at 4% CAGR through 2027.
Who are the top providers of cardiac prosthetic devices?
CryoLife, Inc., TTK Healthcare, and Venus Medtech are well-known manufacturers of cardiac prosthetic devices.
Cardiac Prosthetic Devices Market